Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease

de Rooij NK, Linn FHH, van der Plas JA, Algra A, Rinkel GJE (2007) Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 78:1365–1372

Article  PubMed  PubMed Central  Google Scholar 

Macdonald RL, Schweizer TA (2017) Spontaneous subarachnoid haemorrhage. Lancet 389:655–666. https://doi.org/10.1016/S0140-6736(16)30668-7

Article  PubMed  Google Scholar 

Li MH, Chen SW, Li YD et al (2013) Prevalence of unruptured cerebral aneurysms in chinese adults aged 35 to 75 years: a cross-sectional study. Ann Intern Med 159:514–521. https://doi.org/10.7326/0003-4819-159-8-201310150-00004

Article  PubMed  Google Scholar 

Rinkel GJ, Djibuti M, Algra A, van Gijn J (1998) Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 29:251–256. https://doi.org/10.1161/01.str.29.1.251

Article  CAS  PubMed  Google Scholar 

Schievink WI, Torres VE, Piepgras DG, Wiebers DO (1992) Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3:88–95

Article  CAS  PubMed  Google Scholar 

Nurmonen HJ, Huttunen T, Huttunen J et al (2017) Polycystic kidney disease among 4,436 intracranial aneurysm patients from a defined population. Neurology 89:1852–1859. https://doi.org/10.1212/WNL.0000000000004597

Article  PubMed  Google Scholar 

Perrone RD, Malek AM, Watnick T (2015) Vascular complications in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 11:589–598. https://doi.org/10.1038/nrneph.2015.128

Article  CAS  PubMed  PubMed Central  Google Scholar 

Räisänen S, Frösen J, Kurki M et al (2018) Impact of young age on the presentation of saccular intracranial aneurysms: population-based analysis of 4082 patients. Neurosurgery 82:815–823

Article  PubMed  Google Scholar 

Kim ST, Brinjikji W, Kallmes DF (2016) Prevalence of intracranial aneurysms in patients with connective tissue diseases: a retrospective study. Am J Neuroradiol 37:1422–1426

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rodrigues VJ, Elsayed S, Loeys BL, Dietz HC, Yousem DM (2009) Neuroradiologic manifestations of Loeys-Dietz syndrome type 1. Am J Neuroradiol 30:1614–1619

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oderich G, Sullivan T, Bower T et al (2007) Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 46:475–484

Article  PubMed  Google Scholar 

Chihi M, Gembruch O, Darkwah Oppong M et al (2019) Intracranial aneurysms in patients with tuberous sclerosis complex: a systematic review. J Neurosurg Pediatr 24:174–183

Article  PubMed  Google Scholar 

Korja M, Silventoinen K, McCarron P et al (2010) Genetic epidemiology of spontaneous subarachnoid hemorrhage: Nordic twin study. Stroke 41:2458–2462. https://doi.org/10.1161/STROKEAHA.110.586420

Article  PubMed  Google Scholar 

Wills S, Ronkainen A, van der Voet M et al (2003) Familial intracranial aneurysms: an analysis of 346 multiplex finnish families. Stroke 34:1370–1374

Article  PubMed  Google Scholar 

Zhou S, Dion P, Rouleau G (2018) Genetics of intracranial aneurysms. Stroke 49:780–787

Article  PubMed  Google Scholar 

Kataoka H, Akagawa H, Ushio Y et al (2022) Mutation type and intracranial aneurysm formation in autosomal dominant polycystic kidney disease. Stroke Vasc Interv Neurol 2:e000203. https://doi.org/10.1161/SVIN.121.000203

Article  Google Scholar 

Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJ (2009) Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 8:635–642. https://doi.org/10.1016/S1474-4422(09)70126-7

Article  PubMed  Google Scholar 

Kataoka H, Nitta K, Hoshino J (2023) Visceral fat and attribute-based medicine in chronic kidney disease. Front Endocrinol. https://doi.org/10.3389/fendo.2023.1097596

Article  Google Scholar 

Kataoka H, Mochizuki T, Ohara M et al (2022) Urate-lowering therapy for Ckd patients with asymptomatic hyperuricemia without proteinuria elucidated by attribute-based research in the feather study. Sci Rep 12:3784. https://doi.org/10.1038/s41598-022-07737-9

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Kataoka H, Ono K, Mochizuki T et al (2019) A body mass index-based cross-classification approach for the assessment of prognostic factors in chronic kidney disease progression. Kidney Blood Press Res 44:362–383. https://doi.org/10.1159/000501021

Article  CAS  PubMed  Google Scholar 

Kataoka H, Ohara M, Mochizuki T et al (2020) Sex differences in time-series changes in pseudo-R(2) values regarding hyperuricemia in relation to the kidney prognosis. J Pers Med. https://doi.org/10.3390/jpm10040248

Article  PubMed  PubMed Central  Google Scholar 

Sacristan JA (2015) Clinical research and medical care: towards effective and complete integration. BMC Med Res Methodol 15:4. https://doi.org/10.1186/1471-2288-15-4

Article  PubMed  PubMed Central  Google Scholar 

Butler WE, Barker FG II, Crowell RM (1996) Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: a decision analysis. Neurosurgery 38:506–515. https://doi.org/10.1097/00006123-199603000-00018

Article  CAS  PubMed  Google Scholar 

Horie S, Mochizuki T, Muto S et al (2016) Evidence-based clinical practice guidelines for polycystic kidney disease 2014. Clin Exp Nephrol 20:493–509. https://doi.org/10.1007/s10157-015-1219-7

Article  PubMed  PubMed Central  Google Scholar 

Nishio S, Tsuchiya K, Nakatani S et al (2021) A digest from evidence-based clinical practice guideline for polycystic kidney disease 2020. Clin Exp Nephrol 25:1292–1302. https://doi.org/10.1007/s10157-021-02097-6

Article  PubMed  Google Scholar 

Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated Gfr from serum creatinine in Japan. Am J Kidney Dis 53:982–992. https://doi.org/10.1053/j.ajkd.2008.12.034

Article  CAS  PubMed  Google Scholar 

Kataoka H, Akagawa H, Yoshida R et al (2022) Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease. Sci Rep 12:18056–18056

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Curtis MJ, Bond RA, Spina D et al (2015) Experimental design and analysis and their reporting: new guidance for publication in Bjp. Br J Pharmacol 172:3461–3471. https://doi.org/10.1111/bph.12856

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 165:710–718. https://doi.org/10.1093/aje/kwk052

Article  PubMed  Google Scholar 

Mochizuki T, Tsuchiya K, Nitta K (2013) Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol 17:317–326. https://doi.org/10.1007/s10157-012-0741-0

Article  CAS  PubMed  Google Scholar 

Somlo S, Markowitz GS (2000) The pathogenesis of autosomal dominant polycystic kidney disease: an update. Curr Opin Nephrol Hypertens 9:385–394

Article  CAS  PubMed  Google Scholar 

Sato M, Kataoka H, Ushio Y et al (2020) High serum phosphate level as a risk factor to determine renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. Medicines (Basel). https://doi.org/10.3390/medicines7030013

Article  PubMed  Google Scholar 

Kataoka H, Watanabe S, Sato M et al (2021) Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease. Hep Intl 15:791–803

Article  Google Scholar 

Ushio Y, Kataoka H, Sato M et al (2020) Association between anemia and renal prognosis in autosomal dominant polycystic kidney disease: a retrospective study. Clin Exp Nephrol 24:500–508. https://doi.org/10.1007/s10157-020-01856-1

Article  CAS  PubMed  Google Scholar 

Kataoka H, Shimada Y, Nishio S et al (2023) Public support for patients with intractable diseases in japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol 27:809–811

Article  CAS  PubMed  Google Scholar 

Higashihara E, Nutahara K, Kojima M et al (1998) Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron 80:421–427

Article  CAS  PubMed 

留言 (0)

沒有登入
gif